Product
Aminoglycoside
3 clinical trials
5 indications
Indication
Cystic FibrosisIndication
Cystic Fibrosis Pulmonary ExacerbationIndication
Aminoglycoside ToxicityIndication
Acute Kidney InjuryClinical trial
Adjustment of Aminoglycoside Dosing Based on Peak Serum Concentration and Bacterial Minimal Inhibitory ConcentrationStatus: Recruiting, Estimated PCD: 2025-12-31
Clinical trial
Standardizing Treatments for Pulmonary Exacerbations: A Platform for Evaluating Treatment Decisions to Improve Outcomes (STOP360) Aminoglycoside Study (AG Study)Status: Recruiting, Estimated PCD: 2026-11-15
Clinical trial
Analysis of Risk Factors of Aminoglycines Related Acute Kidney Injury in Hospitalized Patients and Development of Machine Learning ModelStatus: Completed, Estimated PCD: 2023-10-31